# Retrospective Observational Safety Effectiveness With Kuvan in hpA

> **NCT03864029** · — · COMPLETED · sponsor: **BioMarin Pharmaceutical** · enrollment: 26 (actual)

## Conditions studied

- Tetrahydrobiopterin Deficiency

## Interventions

- **DRUG:** KUVAN

## Key facts

- **NCT ID:** NCT03864029
- **Lead sponsor:** BioMarin Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-10
- **Primary completion:** 2018-03-09
- **Final completion:** 2018-07-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03864029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03864029, "Retrospective Observational Safety Effectiveness With Kuvan in hpA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03864029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*